Publications
Detailed Information
Effects of intravenous anesthetics on the activity of glutamate transporter EAAT3 expressed in Xenopus oocytes: evidence for protein kinase C involvement
Cited 12 time in
Web of Science
Cited 14 time in Scopus
- Authors
- Issue Date
- 2006-01-18
- Publisher
- North-Holland
- Citation
- Eur J Pharmacol. 2006 Feb 15;531(1-3):133-9. Epub 2006 Jan 18.
- Keywords
- Alkaloids ; Anesthetics, Intravenous/*pharmacology ; Animals ; Benzophenanthridines ; Dose-Response Relationship, Drug ; Enzyme Inhibitors/pharmacology ; Etomidate/pharmacology ; Excitatory Amino Acid Transporter 3/genetics/*physiology ; Female ; Glutamic Acid/pharmacology ; Ketamine/pharmacology ; Membrane Potentials/drug effects ; Oocytes/*drug effects/metabolism/physiology ; Phenanthridines/pharmacology ; Protein Kinase C/antagonists & inhibitors/metabolism ; Rats ; Staurosporine/pharmacology ; Tetradecanoylphorbol Acetate/pharmacology ; Thiopental/pharmacology ; Xenopus
- Abstract
- We investigated the effects of the intravenous anesthetics, thiopental, etomidate and ketamine, on the activity of one type of glutamate transporters, EAAT3 (excitatory amino acid transporter type 3). Rat EAAT3 was expressed in Xenopus oocytes by injection of its mRNA. Using two-electrode voltage clamp, membrane currents were recorded after the application of L-glutamate (30 microM) in the presence or absence of various concentrations of the anesthetics. Thiopental (0.3-30 microM) and ketamine (3-1000 microM) did not affect EAAT3 activity. Etomidate decreased EAAT3 activity in a concentration-dependent manner (0.10-10 microM). Etomidate at 1 microM significantly decreased the Vmax, but not the Km of EAAT3 for glutamate. Chelerythrine, a protein kinase C (PKC) inhibitor, significantly decreased EAAT3 activity, however, there were no statistical differences among the chelerythrine, etomidate or chelerythrine plus etomidate groups. Likewise, the combination of staurosporine, another PKC inhibitor, and etomidate did not decrease the responses further compared with staurosporine or etomidate alone. Phorbol-12-myrisate-13-acetate, a PKC activator, abolished etomidate-induced decrease in EAAT3 activity. Since our results showed that thiopental and ketamine did not affect EAAT3 activity significantly, EAAT3 may not be a target for their anesthetic effects. Our results also suggest that etomidate, possibly via PKC, decreased EAAT3 activity at clinically relevant concentrations.
- ISSN
- 0014-2999 (Print)
- Language
- English
- URI
- http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1J-4J2M1Y6-1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=bcfeb07816f2841f5a6b38de3e947099
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16413532
https://hdl.handle.net/10371/27840
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.